Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with Plasmodium falciparum

Journal:

Science Translational Medicine

Published:

2025-11-26

DOI:

10.1126/scitranslmed.aea2531

Affiliations:

14

Authors:

41

Go to article

Institutions	Authors	Share
QIMR Berghofer Medical Research Institute, Australia	14.250000 14.250000	0.35
Stanford University, United States of America (USA)	8.000000	0.20
Burnet Institute, Australia	5.833333	0.14
University of the Sunshine Coast (USC), Australia	4.250000	0.10
Medicines for Malaria Venture (MMV), Switzerland	2.333333	0.06
Australian Defence Force Malaria and Infectious Disease Institute, ADF, Australia	2.000000	0.05
The University of Queensland (UQ), Australia	1.333333	0.03
Griffith University, Australia	0.833333	0.02
The George Institute for Global Health (TGI), Australia	0.500000	0.01
The Peter Doherty Institute for Infection and Immunity (Doherty Institute), Australia	0.500000	0.01
University of Basel (UB), Switzerland	0.333333	0.01
Swiss Tropical and Public Health Institute (Swiss TPH), Switzerland	0.333333	0.01
Royal Brisbane and Women's Hospital (RBWH), Australia	0.250000	0.01
Menzies School of Health Research, Australia	0.250000	0.01

Interested in Medical Microbiology?